Compare LMAT & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LMAT | ACHC |
|---|---|---|
| Founded | 1983 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2006 | 2011 |
| Metric | LMAT | ACHC |
|---|---|---|
| Price | $94.30 | $27.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 15 |
| Target Price | ★ $105.80 | $22.67 |
| AVG Volume (30 Days) | 292.9K | ★ 2.3M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | ★ 30.57 | N/A |
| EPS | ★ 0.68 | 0.05 |
| Revenue | $249,602,000.00 | ★ $3,312,769,000.00 |
| Revenue This Year | $14.21 | $5.08 |
| Revenue Next Year | $8.88 | $5.98 |
| P/E Ratio | ★ $138.13 | $524.80 |
| Revenue Growth | ★ 13.53 | 5.04 |
| 52 Week Low | $79.01 | $11.43 |
| 52 Week High | $118.01 | $30.20 |
| Indicator | LMAT | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.80 | 60.19 |
| Support Level | $82.26 | $22.05 |
| Resistance Level | $97.83 | $27.75 |
| Average True Range (ATR) | 3.02 | 1.15 |
| MACD | 0.63 | 0.25 |
| Stochastic Oscillator | 61.26 | 88.89 |
LeMaitre Vascular Inc is a provider of medical devices and human tissue cryopreservation services mainly used in the treatment of peripheral vascular disease, end-stage renal disease, and cardiovascular disease. The company develops, manufactures, and markets vascular devices to address the needs of vascular surgeons and, to a lesser extent, other specialties such as cardiac surgeons, general surgeons, and neurosurgeons. Its diversified portfolio consists of branded products used in arteries and veins that are well known to vascular surgeons. It operates across the Americas, Europe, the Middle East and Africa, and Asia Pacific, with the majority of its revenue generated from the Americas.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Its facilities and services are classified into the following categories: acute inpatient psychiatric facilities; specialty treatment facilities; CTCs; and residential treatment centers. In which Acute inpatient psychiatric facilities contribute the majority of revenue in the United States. The Company has one reportable segment, behavioral healthcare services. The behavioral healthcare services segment provides inpatient and outpatient behavioral healthcare services.